openaccessgovernment2d
New NHS treatment offers hope for children with Lennox–Gastaut syndrome
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...
pharmaphorum3d
UCB's non-cannabis drug for severe epilepsy gets NHS okay
The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...
National Institute for Health and Care Excellence3d
New life-changing treatment option recommended to help control seizures for type of rare epilepsy
New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...
NHS England3d
NHS rolls out life-changing treatment offering ‘new hope’ for hundreds of children with severe epilepsy
Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures, providing new hope for them and their ...
Harmony Biosciences CEO says pipeline could push company over $3B in sales
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
pharmaphorum4d
Buoyed by muscular dystrophy data, Avidity raises $345m
The drug also reduced creatine kinase levels – a biomarker for muscle damage – to near ... by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from Stoke ...
National Health Executive3d
Groundbreaking new child epilepsy treatment
Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...